Analysis of the occurrence and clinical characteristics of immune-related adverse events caused by pembrolizumab in elderly patients with advanced lung cancer

Chen Lu, Xu Lei

PDF(417 KB)
PDF(417 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (4) : 211-217. DOI: 10.3760/cma.j.cn114015-20220714-00632

Analysis of the occurrence and clinical characteristics of immune-related adverse events caused by pembrolizumab in elderly patients with advanced lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(4): 211-217 https://doi.org/10.3760/cma.j.cn114015-20220714-00632

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(417 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉